BRIEF-Aveo Pharmaceuticals Q1 loss per share $0.13
May 10, 2016 at 16:24 PM EDT
* Says believe that its cash resources would allow company to fund its current operations into Q4 of 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
